SCHEMBL18627353

SCHEMBL18627353

C[C@@H]1CN(S(=O)(=O)c2ccccc2)[C@@H](COCc2ccccc2)CN1C(=O)OC(C)(C)C

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.48
NR1H2 P55055 5/20 0.46
GPR119 Q8TDV5 4/20 0.46
NR1H3 Q13133 4/20 0.46
HSD11B1 P28845 1/20 0.44
MMP1 P03956 1/20 0.41
MMP2 P08253 1/20 0.41
MMP3 P08254 1/20 0.41
MMP9 P14780 1/20 0.41
MMP13 P45452 1/20 0.41
PARP1 P09874 1/20 0.39
KLK7 P49862 1/20 0.39
PDK1 Q15118 1/20 0.39
PDK2 Q15119 1/20 0.39
PDK3 Q15120 1/20 0.39
PDK4 Q16654 1/20 0.39
ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17086527 0.88 NR1H2 (0.43) L3MBTL1NR1H2NR1H3HSD11B1MMP1
SCHEMBL17078149 0.88 NR1H2 (0.43) L3MBTL1NR1H2NR1H3HSD11B1MMP1
SCHEMBL18627354 0.86 GPR119 (0.42) NR1H2GPR119NR1H3PARP1KLK7
SCHEMBL28549464 0.82 PARP1 (0.46) L3MBTL1NR1H2GPR119NR1H3PARP1
SCHEMBL18622463 0.81 NR1H2 (0.39) NR1H2GPR119NR1H3MMP1MMP2
SCHEMBL7056205 0.81 MMP1 (0.48) MMP1MMP2MMP3MMP9MMP13
SCHEMBL17078092 0.81 L3MBTL1 (0.51) L3MBTL1MMP1MMP2MMP3MMP9
SCHEMBL17078090 0.81 L3MBTL1 (0.51) L3MBTL1MMP1MMP2MMP3MMP9
SCHEMBL7921498 0.77 KLK7 (0.47) L3MBTL1NR1H2GPR119NR1H3PARP1
SCHEMBL7921496 0.77 KLK7 (0.47) L3MBTL1NR1H2GPR119NR1H3PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170073354-A1 PIPERAZINE DERIVATIVES AS HIV PROTEASE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2017-03-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170073354-A1 PIPERAZINE DERIVATIVES AS HIV PROTEASE INHIBITORS PREP, CTSZ, PEPD L3MBTL1 4409/4885NR1H2 1893/4885GPR119 3589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.